NO931709D0 - NUCLEIC ACID AMPLIFICATION USING TWO ENZYMERS, SELF-SUSTAINING SEQUENCE REPLICATION - Google Patents

NUCLEIC ACID AMPLIFICATION USING TWO ENZYMERS, SELF-SUSTAINING SEQUENCE REPLICATION

Info

Publication number
NO931709D0
NO931709D0 NO931709A NO931709A NO931709D0 NO 931709 D0 NO931709 D0 NO 931709D0 NO 931709 A NO931709 A NO 931709A NO 931709 A NO931709 A NO 931709A NO 931709 D0 NO931709 D0 NO 931709D0
Authority
NO
Norway
Prior art keywords
enzymers
self
nucleic acid
acid amplification
sequence replication
Prior art date
Application number
NO931709A
Other languages
Norwegian (no)
Other versions
NO931709L (en
Inventor
Eoin David Fahy
Deborah Yantis Kwoh
Thomas Raymond Gingeras
Original Assignee
Siska Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siska Diagnostics Inc filed Critical Siska Diagnostics Inc
Publication of NO931709D0 publication Critical patent/NO931709D0/en
Publication of NO931709L publication Critical patent/NO931709L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO93931709A 1990-11-13 1993-05-11 NUCLEIC ACID AMPLIFICATION USING TWO ENZYMERS, SELF-SUSTAINING SEQUENCE REPLICATION NO931709L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61268890A 1990-11-13 1990-11-13
PCT/US1991/008488 WO1992008800A1 (en) 1990-11-13 1991-11-13 Nucleic acid amplification by two-enzyme, self-sustained sequence replication

Publications (2)

Publication Number Publication Date
NO931709D0 true NO931709D0 (en) 1993-05-11
NO931709L NO931709L (en) 1993-07-12

Family

ID=24454235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931709A NO931709L (en) 1990-11-13 1993-05-11 NUCLEIC ACID AMPLIFICATION USING TWO ENZYMERS, SELF-SUSTAINING SEQUENCE REPLICATION

Country Status (13)

Country Link
EP (1) EP0572417A4 (en)
JP (1) JPH06502767A (en)
AU (1) AU9131591A (en)
CA (1) CA2096013A1 (en)
FI (1) FI932144A0 (en)
HU (1) HUT69772A (en)
IE (1) IE913930A1 (en)
IL (1) IL100040A (en)
NO (1) NO931709L (en)
NZ (1) NZ240574A (en)
PT (1) PT99500A (en)
WO (1) WO1992008800A1 (en)
ZA (1) ZA918965B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5673794A (en) * 1992-11-19 1994-06-08 Matthew C. Biery Production of monoclonal recombinant antibodies without the use of hybridomas by (in vitro) spleen fragment culture combined with isothermal self-sustained sequence replication of rna
EP0682121B1 (en) * 1993-12-01 2002-08-28 Toyo Boseki Kabushiki Kaisha Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes
US5705366A (en) * 1994-09-15 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
JPH08131171A (en) * 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd Reverse transcriptase-stabilized composition
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
WO2000000638A2 (en) * 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
JP2001029078A (en) * 1999-07-16 2001-02-06 Shimadzu Corp Amplification of rna
EP1307469B1 (en) 2000-08-03 2008-01-23 Boehringer Mannheim Gmbh Nucleic acid binding compounds containing pyrazolo¬3,4-d pyrimidine analogues of purin-2,6-diamine and their uses
US6841349B2 (en) 2001-05-07 2005-01-11 Applera Corporation Applied Biosystems Group Methods for the reduction of stutter in microsatellite amplification
US6780588B2 (en) * 2001-05-07 2004-08-24 Applera Corporation Methods for the reduction of stutter in microsatellite amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
DE60316660T3 (en) 2002-01-08 2016-01-28 Roche Diagnostics Gmbh USE OF A SILICA MATERIAL IN AMPLIFICATION
US7122314B2 (en) 2002-01-30 2006-10-17 Id Biomedical Corporation Methods for detecting vancomycin-resistant microorganisms and compositions therefor
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
DE10240868A1 (en) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Improved procedures for the synthesis of nucleic acids
EP1590362B8 (en) 2003-01-29 2015-06-03 Epigenomics AG Improved method for bisulfite treatment
JP2004357502A (en) * 2003-05-30 2004-12-24 Olympus Corp Method for processing information using nucleic acid molecule
JPWO2006006722A1 (en) 2004-07-13 2008-05-01 武田薬品工業株式会社 How to regulate cell function
EP1632578A1 (en) 2004-09-03 2006-03-08 Roche Diagnostics GmbH DNA decontamination method
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
US8420315B2 (en) 2007-08-06 2013-04-16 Orion Genomics Llc Single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
CA2639416C (en) 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
WO2009059317A2 (en) 2007-11-01 2009-05-07 University Of Iowa Research Foundation Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
AU2010213727A1 (en) 2009-02-11 2011-09-29 Orion Genomics Llc Combinations of polymorphisms for determining allele-specific expression of IGF2
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
US20130143214A1 (en) 2010-06-04 2013-06-06 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
WO2012040619A2 (en) 2010-09-24 2012-03-29 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
WO2012054727A1 (en) 2010-10-22 2012-04-26 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
WO2013030167A1 (en) 2011-08-31 2013-03-07 F. Hoffmann-La Roche Ag Responsiveness to angiogenesis inhibitors
AU2012300986A1 (en) 2011-08-31 2014-02-13 F. Hoffmann-La Roche Ag Method for predicting risk of hypertension associated with anti-angiogenesis therapy
CN103930111A (en) 2011-09-19 2014-07-16 霍夫曼-拉罗奇有限公司 Combination treatments comprising C-MET antagonists and B-RAF antagonists
ES2729554T3 (en) 2011-10-21 2019-11-04 Chronix Biomedical Biomarkers of circulating nucleic acids associated with colorectal cancer
CA2854568A1 (en) 2011-11-23 2013-05-30 Life Sciences Research Partners Vzw Responsiveness to angiogenesis inhibitors
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
HRP20190209T4 (en) 2013-05-29 2023-09-15 Chronix Biomedical Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients
SG10201808565QA (en) 2014-03-31 2018-11-29 Debiopharm Int Sa Fgfr fusions
WO2016077366A1 (en) 2014-11-10 2016-05-19 Genentec, Inc. Therapeutic and diagnostic methods for il-33-mediated disorders
JP6966681B2 (en) 2015-04-24 2021-11-17 アティラ バイオシステムズ インコーポレイテッドAtila Biosystems Incorporated Amplification with primers with limited nucleotide composition
EP3995589A1 (en) 2015-08-17 2022-05-11 Kura Oncology, Inc. Methods of treating cancer patients with farnesyl transferase inhibitors
WO2017184968A1 (en) 2016-04-22 2017-10-26 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
CA3042747A1 (en) 2016-11-03 2018-05-11 Kura Oncology, Inc. Methods of treating cancer patients with farnesyltransferase inhibitors
US10137121B2 (en) 2017-02-21 2018-11-27 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
CN109475550A (en) 2017-02-21 2019-03-15 库拉肿瘤学公司 Use the method for farnesyl transferase inhibitor treating cancer
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
WO2019032489A1 (en) 2017-08-07 2019-02-14 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
CA3226165A1 (en) 2018-02-09 2019-08-15 Genentech, Inc. Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseases
EP3873469A2 (en) 2018-11-01 2021-09-08 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US20220142983A1 (en) 2019-03-01 2022-05-12 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
AU2020254492A1 (en) 2019-03-29 2021-11-11 Kura Oncology, Inc. Methods of treating Squamous Cell Carcinomas with farnesyltransferase inhibitors
TW202102218A (en) 2019-04-01 2021-01-16 美商庫拉腫瘤技術股份有限公司 Methods of treating cancer with farnesyltransferase inhibitors
US20220305001A1 (en) 2019-05-02 2022-09-29 Kura Oncology, Inc. Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
JP2023516497A (en) 2020-03-13 2023-04-19 メドイミューン・リミテッド Therapeutic Methods for Treating Subjects with Risk Alleles in IL33
WO2024015331A1 (en) 2022-07-12 2024-01-18 Genentech, Inc. Therapeutic and diagnostic methods for multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
KR0148265B1 (en) * 1988-12-16 1998-10-15 에프.지이.엠 헤르만스 Self-sustained sequence replication system
ES2091225T3 (en) * 1989-07-11 1996-11-01 Gen Probe Inc METHODS FOR AMPLIFICATION OF NUCLEIC ACID SEQUENCES.

Also Published As

Publication number Publication date
IL100040A (en) 1995-12-31
FI932144A (en) 1993-05-12
JPH06502767A (en) 1994-03-31
ZA918965B (en) 1992-08-26
HUT69772A (en) 1995-09-28
NO931709L (en) 1993-07-12
IE913930A1 (en) 1992-06-17
EP0572417A1 (en) 1993-12-08
CA2096013A1 (en) 1992-05-14
NZ240574A (en) 1994-10-26
AU9131591A (en) 1992-06-11
PT99500A (en) 1992-10-30
FI932144A0 (en) 1993-05-12
WO1992008800A1 (en) 1992-05-29
EP0572417A4 (en) 1994-11-23
HU9301369D0 (en) 1993-10-28
IL100040A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
NO931709D0 (en) NUCLEIC ACID AMPLIFICATION USING TWO ENZYMERS, SELF-SUSTAINING SEQUENCE REPLICATION
FI884966A (en) N-SUBSTITUTE DERIVAT AV 1-DESOXINOJIRIMYCIN OCH DESOXIMANNONOJIRIMYCIN, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL.
DE69015008D1 (en) Handcart.
NO904634D0 (en) AMPLIFICATION OF NUCLEIC ACID USING LIGARABLE, HAARNAAL PROBLEMS AND TRANSCRIPTION.
FI880428A (en) YTANTIGENER AV HEPATIT B VIRUS OCH HYBRIDANTIGENER INNEHAOLLANDE DESAMMA.
DE3879627D1 (en) SHELL CURVE AMPLIFIER.
FI883129A (en) FOERFARANDE FOER FRAMSTAELLNING AV ORGANISERADE STRUKTURER AV KOLLAGEN, SPECIELLT AV MAENSKLIGT URSPRUNG OCH MOTSVARANDE ORGANISERADE STRUKTURER AV KOLLAGEN.
FI885735A (en) SYSTEM FOER GODSTRANSPORT, VILKA AER TRANSFORMERBARA TILL JAERNVAEGSFORDON OCH MED SYSTEMET ANVAENDBARA BOGGIER.
FI882993A0 (en) SILIKAPARTIKLAR, SAETT FOER FRAMSTAELLNING AV SILIKAPARTIKLAR OCH ANVAENDNING AV DESSA.
FI881434A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV IMIDAZOPYRIDINDERIVAT VILKA AER TERAPEUTISKT ANVAENDBARA.
FI895593A0 (en) ANORDIN I SYNNERHET FOER BEHANDLING AV KRAEMER OCH PASTOR.
FI882634A (en) PRESSVALS, VARS BOEJNING AER INSTAELLBAR.
FI885707A (en) FOERFARANDE FOER FRIHAOLLNING AV GENOMSTROEMNINGSKANALEN TILL EN STAONGGJUTMASKINS GLIDLUCKA.
DE3850923D1 (en) Operational amplifier stages.
FI871990A0 (en) ANORDNING FOER DISTRIBUERING AV VED TILL MATNINGSSCHAKT FOER SLIPMASKINER.
FI875327A (en) FOERFARANDE OCH ANORDNING FOER FRAMSTAELLNING AV BETONGSTOMELEMENT, ISYNNERHET BJAELKAR.
DE69010711D1 (en) Differential amplifier.
FI881848A (en) AV MEDANDRA FOERBUNDNA DELAR SAMMANSATT SLANG, SPECIELLT KORVSKINNN AV KONSTMATERIAL.
FI873317A (en) FOERFARANDE OCH ANORDNING FOER BESTRYKNING AV LAONGSTRAECKTA STAOLSTYCKEN, ISYNNERHET BETONGSTAOL OCH STAOLPROFILER.
FI874598A (en) ANORDNING FOER SAMLING AV BAER FRAON BUSKAR.
FI872588A0 (en) FOERFARANDE, SAENDARE OCH MOTTAGARE FOER OEVERFOERANDE AV DIGITALISK TILLAEGGSINFORMATION.
ATE84527T1 (en) PYRIMIDI DERIVATIVES.
FI895038A0 (en) SAMKATALYTISK KOMPOSITION, VILKEN AER ANVAENDBAR FOER POLYMERISERING AV ALFA-OLEFINER.
FI870538A (en) INTRAVENOEST FILTER, ANORDNING OCH FOERFARANDE FOER DERAS FOERBEREDELSE TILL OPERATIONEN.
FI870165A0 (en) ANORDNING FOER MATNING AV FLUIDISERINGSGAS TILL EN VIRVELBAEDDSREAKTOR.